Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma

By Lee Myung   Woo In   Kang Jin-Hyoung   Hong Young   Lee Kyung  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 6, 2004-06 ,pp. : 346-350

Springer Publishing Company

Access to resources Recommend Favorite

Squamous Oesophageal Cancer can be Downstaged Using Protracted Venous Infusion of 5-Fluorouracil with Epirubicin and Cisplatin (ECF)

By Andreyev H.J.N.   Norman A.R.   Cunningham D.   Padhani A.R.   Hill A.S.   Ross P.J.   Webb A.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2209-2214

Elsevier

Access to resources Recommend Favorite

Epirubicin, Cisplatin, and Prolonged or Brief Infusional 5-Fluorouracil in the Treatment of Carcinoma of Unknown Primary Site

By Karapetis C.S.   Yip D.   Virik K.   Strickland A.   Ryder K.   Cowling M.   Harper P.G.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

By Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 661-666

Elsevier

Access to resources Recommend Favorite